文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Nonmedication Devices in Development for the Treatment of Alzheimer's Disease.

作者信息

Sleem Tamara, Decourt Boris, Sabbagh Marwan N

机构信息

Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.

Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, School of Medicine, Lubbock, TX, USA.

出版信息

J Alzheimers Dis Rep. 2024 Feb 16;8(1):241-255. doi: 10.3233/ADR-230115. eCollection 2024.


DOI:10.3233/ADR-230115
PMID:38405349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10894612/
Abstract

Huge investments continue to be made in treatment for Alzheimer's disease (AD), with more than one hundred drugs currently in development. Pharmacological approaches and drug development, particularly those targeting amyloid-β, have dominated the therapeutic landscape. At the same time, there is also a growing interest in devices for treating AD. This review aimed to identify and describe devices under development for AD treatment. In this review, we queried the devices that are in development for the treatment of AD. PubMed was searched through the end of 2021 using the terms "device," "therapeutics," and "Alzheimer's" for articles that report on devices to treat AD. Ten devices with 31 references were identified as actively being developed for the treatment of AD. Many of these devices are far along in development. Device-based therapies are often overlooked when evaluating treatment approaches to AD. However, many devices for treating AD are in development and some show promising results.

摘要

相似文献

[1]
Nonmedication Devices in Development for the Treatment of Alzheimer's Disease.

J Alzheimers Dis Rep. 2024-2-16

[2]
The Alzheimer's disease drug development landscape.

Alzheimers Res Ther. 2021-11-11

[3]
A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.

Curr Pharm Des. 2023

[4]
Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.

Ann Integr Mol Med. 2020

[5]
Alzheimer's disease drug development pipeline: 2022.

Alzheimers Dement (N Y). 2022-5-4

[6]
Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules.

Curr Top Med Chem. 2017

[7]
Emerging amyloid and tau targeting treatments for Alzheimer's disease.

Expert Rev Neurother. 2017-5-19

[8]

2008-6

[9]
Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.

Expert Opin Pharmacother. 2015

[10]
Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease.

Infect Disord Drug Targets. 2024

本文引用的文献

[1]
An update on the use of gamma (multi)sensory stimulation for Alzheimer's disease treatment.

Front Aging Neurosci. 2022-12-15

[2]
Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies.

PLoS One. 2022

[3]
Transcranial Electromagnetic Treatment Stops Alzheimer's Disease Cognitive Decline over a 2½-Year Period: A Pilot Study.

Medicines (Basel). 2022-8-3

[4]
Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases.

J Biomed Sci. 2022-6-13

[5]
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease.

Ann Neurol. 2022-8

[6]
Alzheimer's disease drug development pipeline: 2022.

Alzheimers Dement (N Y). 2022-5-4

[7]
2022 Alzheimer's disease facts and figures.

Alzheimers Dement. 2022-4

[8]
Working Memory and Transcranial-Alternating Current Stimulation-State of the Art: Findings, Missing, and Challenges.

Front Psychol. 2022-2-14

[9]
Systematic review: auditory stimulation and sleep.

J Clin Sleep Med. 2022-6-1

[10]
Impact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer's disease.

Alzheimers Res Ther. 2021-12-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索